226
Participants
Start Date
March 31, 2008
Primary Completion Date
November 30, 2009
Study Completion Date
December 31, 2009
124-Iodine-cG250 (124I-cG250)
i.v. and PET/CT scan 4+/-2 days after administration
CT
contrast enhanced CT scan
Memorial Sloan-Kettering Cancer Center, New York
UNC School of Medicine-Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
H. Lee Moffitt Cancer Center & Research Center, Tampa
Ohio State University, Columbus
Cleveland Clinic Foundation, Cleveland
Nevada Cancer Institute, Las Vegas
Stanford University Medical Center, Stanford
David Geffen School of Medicine, UCLA, Los Angeles
Lahey Clinic, Burlington
University of Michigan, Ann Arbor
Fox Chase Cancer Center, Philadelphia
Hospital of the University of Pennsylvania, Philadelphia
MD Anderson, Houston
Lead Sponsor
Heidelberg Pharma AG
INDUSTRY